Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Reprod Biomed Online ; 38(5): 845-852, 2019 May.
Article in English | MEDLINE | ID: mdl-30930183

ABSTRACT

RESEARCH QUESTION: What concentration of anti-Müllerian hormone (AMH) corresponds to an antral follicle count (AFC) >15 for determination of ovarian reserve? DESIGN: A prospective study conducted at 13 US fertility clinics in women aged 21-44 years who presented for AFC evaluation by transvaginal ultrasound. Serum samples were collected at the time of AFC evaluation (menstrual cycle day 2-4). AMH concentrations were measured by the Elecsys® AMH immunoassay; oestradiol and follicle-stimulating hormone (FSH) concentrations were also measured. The serum AMH cut-off able to detect AFC >15 with high sensitivity was determined (derivation cohort). Clinical performance of the AMH assay at the derived cut-off was evaluated (validation cohort). Receiver operating characteristic (ROC) analyses were also performed. RESULTS: In the derivation cohort (n = 306), an optimal serum AMH cut-off value of 1.77 ng/ml was determined to correspond to AFC >15 with 89.63% sensitivity and 69.01% specificity, using the Elecsys AMH assay. In the validation cohort (n = 856), this 1.77 ng/ml cut-off could identify women with an AFC >15 with a sensitivity of 88.34% and a specificity of 68.29%; corresponding positive predictive and negative predictive values were 75.19% and 84.34%, respectively. ROC analyses demonstrated that AMH performed better than oestradiol or FSH in predicting AFC, with area under the curves of 85.7%, 57.1% and 69.7%, respectively, in the validation cohort. CONCLUSION: The Elecsys AMH immunoassay provides a robust and fully automated method to measure serum AMH levels. Women with AMH values below the cut-off of 1.77 ng/ml are unlikely to have AFC >15.


Subject(s)
Anti-Mullerian Hormone/blood , Immunoassay/statistics & numerical data , Ovarian Reserve , Adult , Female , Humans , Prospective Studies , Young Adult
2.
Urology ; 124: 218-222, 2019 02.
Article in English | MEDLINE | ID: mdl-30528713

ABSTRACT

OBJECTIVE: To evaluate ultrasonically determined bladder wall thickness (BWT) and prostatic calcification presence, in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), and to correlate the findings with patient characteristics and the urinary, psychosocial dysfunction, organ specific, infection and neurological/systemic symptoms, and tenderness (UPOINT) classification system. MATERIAL AND METHODS: Between January 2008 and December 2017, data of 1294 patients diagnosed with chronic prostatitis, in a single urology clinic, meeting a number of selective inclusion/exclusion criteria, were retrospectively analyzed. Patients, compliant to fill out all requested questionnaires, between the ages of 21-65 years were included to the study. Exclusion criteria were noncompliance of filling out required questionnaires, acute and/or chronic bacterial prostatitis, history of genitourinary cancer, history of recent prostate surgery, and diagnosis of neurological diseases affecting the bladder. RESULTS: The median patient age and UPOINT subdomain was determined as 37 (IQR = 13, range 21-65) and 2 (IQR = 1, range 0-5), respectively. Median values for BWT, National Institute of Health-Chronic Prostatitis Symptom Index (NIH-CPSI), and International Index of Erectile Function were 3 (IQR = 1, range 2-6, 7), 4 (IQR = 6, range 1-23), and 25 (IQR = 10, range 1-30), respectively. The presence of calcification demonstrated a significant association with total NIH-CPSI score and BWT, whereas its relation with age and total UPOINT score was insignificant. However in contrast to calcification status, BWT ≥3.3 showed a strong and statistically significant relation to all the described measurements. CONCLUSION: Measurement of BWT can be used as an accessible and objective method for the diagnose of CP/CPPS according to UPOINT scoring system.


Subject(s)
Calcinosis/diagnostic imaging , Prostatic Diseases/diagnostic imaging , Prostatitis/diagnostic imaging , Urinary Bladder/diagnostic imaging , Urinary Bladder/pathology , Adult , Aged , Calcinosis/complications , Calcinosis/psychology , Correlation of Data , Humans , Male , Middle Aged , Prostatic Diseases/complications , Prostatic Diseases/psychology , Prostatitis/classification , Prostatitis/complications , Prostatitis/psychology , Retrospective Studies , Symptom Assessment , Ultrasonography
3.
Int J Surg Case Rep ; 21: 121-4, 2016.
Article in English | MEDLINE | ID: mdl-26975033

ABSTRACT

BACKGROUND: Malignant triton tumors (MTT) represent a rare subset of tumors with rhabdomyoblastic differentiation within the heterogeneous group of malignant peripheral nerve sheath tumors (MPNST). CASE PRESENTATION: Here, we report on a case of a 25 year-old male with a history of neurofibromatosis type I and MTT of the mediastinal wall who presented in our clinic with a pelvic tumor and multiple hypervascular mesenteric masses and underwent resection. Upon resection, histological findings revealed an MTT of the omentum and an atypical neurofibroma of the pelvis with focal transitions to a low-grade MPNST. The patient relapsed just one month later and died 3 months after the surgery. CONCLUSION: Clinically, MTTs are characterized as highly aggressive tumors that are fast-growing and prone to local recurrence and distant metastasis. To date, there is no treatment consensus available yet and many patients succumb to the disease shortly after diagnosis. This is because the pathogenesis of MTT remains unknown and patients with MTT are often diagnosed at a late stage of disease. Our case presents valuable teaching points in terms of providing a possible progression model based on the coexistence of a low-grade MPNST and MTT in the context of NF1 and an atypical neurofibroma in this patient. Close monitoring of patients with NF1 and atypical neurofibromas or MPNST might therefore help to diagnose MTT at an earlier stage.

4.
Cell Death Differ ; 22(7): 1192-202, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25613377

ABSTRACT

Cancer stem cells (CSCs) have been implicated in the initiation and maintenance of tumour growth as well as metastasis. Recent reports link stemness to epithelial-mesenchymal transition (EMT) in cancer. However, there is still little knowledge about the molecular markers of those events. In silico analysis of RNA profiles of 36 pancreatic ductal adenocarcinomas (PDAC) reveals an association of the expression of CD95 with EMT and stemness that was validated in CSCs isolated from PDAC surgical specimens. CD95 expression was also higher in metastatic pancreatic cells than in primary PDAC. Pharmacological inhibition of CD95 activity reduced PDAC growth and metastasis in CSC-derived xenografts and in a murine syngeneic model. On the mechanistic level, Sck was identified as a novel molecule indispensable for CD95's induction of cell cycle progression. This study uncovers CD95 as a marker of EMT and stemness in PDAC. It also addresses the molecular mechanism by which CD95 drives tumour growth and opens tantalizing therapeutic possibilities in PDAC.


Subject(s)
Carcinoma, Pancreatic Ductal/physiopathology , Neoplasm Metastasis , Pancreatic Neoplasms/physiopathology , Shc Signaling Adaptor Proteins/physiology , fas Receptor/physiology , Animals , Biomarkers, Tumor , Carcinoma, Pancreatic Ductal/metabolism , Epithelial-Mesenchymal Transition , Female , Humans , Mice , Pancreatic Neoplasms/metabolism , Signal Transduction , Src Homology 2 Domain-Containing, Transforming Protein 2 , Xenograft Model Antitumor Assays
5.
Spectrochim Acta A Mol Biomol Spectrosc ; 67(5): 1276-80, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17204450

ABSTRACT

The radicals formed in the flash photolysis of 2-methylbut-1-ene and subsequent reactions have been investigated by kinetic spectroscopy and gas liquid chromatography. Less than 10% of photo products are formed by a molecular made of fission of the excited olefin, and of the radical modes the relative probabilities of band fission, beta(CH):beta(CH):alpha(CC) are 13:1.37:1. The extinction coefficients of beta-methallyl radical measured experimentally for all the absorption bands. The decay of the beta-methallyl radical was second order. The rate constant for the beta-methallyl radical recombination experimentally measured was 2.6+/-0.3 x 10(10) l mol(-1)s(-1) at 295+/-2K. The spectrum image showing the absorption bands was examined by image processing techniques in order to improve the visual experience of each band by localizing to a specific region of interest. Experimental results illustrate how the exact location of absorption bands was clearly extracted from the spectral image and further improvements in the visual detection of absorption bands.


Subject(s)
Allyl Compounds/chemistry , Gases/chemistry , Absorption , Alkenes/chemistry , Free Radicals , Kinetics , Photolysis , Spectrophotometry , Time Factors
6.
Spectrochim Acta A Mol Biomol Spectrosc ; 67(3-4): 582-5, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17045836

ABSTRACT

The ultraviolet absorption and emissions as well as Stokes and anti-Stokes Raman scatterings of spectroscopically pure 5H-dibenzo(a,d)cycloheptene-5-ol were investigated by flash and laser-flash photolysis technique in solution at room temperature and at 77K. The whole spectrum, absorption, excitation, prompt and delayed fluorescence, T-T absorption spectra were recorded photographically and photoelectrically in the ultraviolet and visible region and phosphorescence spectrum, Stokes, anti-Stokes scatterings were recorded at 77K.


Subject(s)
Dibenzocycloheptenes/chemistry , Scattering, Radiation , Spectrum Analysis, Raman , Absorptiometry, Photon , Cyclohexanes/chemistry , Ethanol/chemistry , Hydrogen Bonding , Lasers , Methanol/chemistry , Molecular Structure , Photolysis , Solutions/chemistry , Spectrometry, Fluorescence , Spectrophotometry, Ultraviolet , Temperature , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...